About
Technology
Issues
FAQ
Links
Official Page
Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and
BRCA1
/
2
Mutation–Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.